As a part of a research on anti-inflammatory analgesic compounds 3-methyl substituted pyrazolotria-zolopyrimidin-4-one and pyrazolothiazolopyrimidin-4-onederivatives were prepared by previously reported procedures. None of the compounds showed improved activity when compared with the previously reported unsubstituted analogs.